65,437 trials
Ankylosing Spondylitis
Primary: Number of Responders With a Reduction of Signs and Symptoms of Ankylosing Spondylitis (AS) as Measured With ASAS International Working Group Response Criteria (ASAS 20)…
Dry Eye
Primary: Drop Comfort — 0.55; 0.60 Units on a scale
Cystic Fibrosis · Pancreatic Exocrine Insufficiency
Primary: Coefficient of Fat Absorption (%) — 47.41; 82.81 Percentage — p=<0.001
Antifungal Prophylaxis of Invasive Fungal Infections
Primary: Success at Day 180: Percent of Responders (Randomization Strata) — 59.1; 44.7; 52.5; 25.9 percent of participants
Seasonal Allergic Rhinitis
Primary: Mean Percent Change in Reflective Total Nasal Symptom Score (rTNSS) From Baseline — -45.37; -47.35 Percent change
Liver Transplantation
Primary: Change From Baseline in Glomerular Filtration Rate (GFR) at 12 Months Posttransplant — 1.2; 19.7 Percent change in GFR (mL/min) — p=0.0012
Contraception
Primary: Pearl Index — 0.17; 0.82; 0.00 Number per 100 women years
Dry Eye
Primary: Visual Blur — 27.7; 33.55 Units on a scale
Type 2 Diabetes
Primary: Change From Baseline in 24-Hour Mean Weighted Glucose (MWG) at Week 4 — 177.5; 181.2; 163.8; 184.2 mg/dL — p=0.0001
Dry Eye
Primary: Drop Comfort Upon Instillation — 1.1; 1.4 Units on a scale
Pulmonary Disease, Chronic Obstructive
Primary: Post-dose TGV(FRC) (After 8 Weeks) — 4.99; 5.07 Litres — p=0.0482
Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2
Primary: Blood Sample of Sufficient Volume to Yield a Valid Meter Reading — 245; 246; 124; 63 Participants
Dry Eye
Primary: Drop Comfort Upon Instillation — 1.7; 1.3 Units on a scale
Acne Vulgaris
Primary: Comparative Assessment of Facial Irritation and Cutaneous Effects. — 1.1; 2.7; 3.2; 6.2 Scores on a Scale
Diabetes
Primary: Number of A1C Results Either Equal To Or Within +/- 13.5% of the Laboratory Method (ACCURACY) — 94; 71 number of A1c results